Market by Product Type, Application, and Country Outlook | Forecast 2022-2028
Based
on Triton’s research report, the Middle East and Africa medical enzymes market
is expected to witness growth at a CAGR
of 7.16% during the forecast period 2022-2028.
Report scope can be customized per your requirements. Request For Customization
The
countries studied in the given region comprise:
•       Â
United Arab Emirates
•       Â
Saudi Arabia
•       Â
Turkey
•       Â
South Africa
•       Â
Rest of Middle East & Africa
Saudi
Arabia secures the majority of shares in the medical enzymes market. In the region, non-communicable diseases like
heart disease and diabetes have caused premature deaths. This rise in chronic
conditions, along with the aging population and health awareness, has fueled
the adoption of medical enzymes. The application of enzymes in medical
cleaning, government reforms, and rising healthcare expenditure also boosts the
market’s growth.
In Saudi Arabia, the government announced
significant spending on healthcare and social development in 2022. As per
estimates, government expenditure accounts for around 60% of healthcare
spending. Moreover, the government plans to invest heavily in developing the
healthcare infrastructure under Vision 2030. This step will increase the
private sector contribution by 2030. Therefore, the surge in healthcare
expenditure is anticipated to support the medical enzymes market’s growth over
the forecast period.
As per WHO, one-third of adults are obese in the
United Arab Emirates. The high prevalence of lifestyle diseases boosts the
demand for medical enzymes. Along with this, the rise in healthcare expenditure
and the developing pharmaceutical industry have soared the demand for medical
enzymes. Therefore, these factors, along with technological advancements and
investments in R&D, are anticipated to support the medical enzymes market’s
growth.
Benzonase endonuclease finds application in
biotechnological processing, such as reducing viscosity caused by nucleic
acids. This prevents cell clumping and purification of viral vaccines.
Moreover, they help prepare samples in chromatography and electrophoresis. The market’s growth is assessed based on
product type and application. The product type is sectioned into
endonuclease, hydrolase, thrombolytic enzyme, and digestive enzyme. The
endonuclease category is sub segmented into benzonase and other endonucleases.
The
major companies in the market consist of Advances Enzymes, Sanofi SA, CPC
Biotech, Codexis, Amano Enzyme, and BBI Solutions.
CPC Biotech is engaged in providing analytical
enzymes for quality control. It has distribution facilities across various
countries, including Egypt and Turkey. The company relies mainly on local
distributors for sale in specific regions. Its product line includes enzymes
for pharmaceutical QC. Besides this, the company developed an enzymatic product
useful for macrolides inactivation, finding applications in sterility testing
and others. CPC serves clients across multiple regions, including the Middle East
and Africa.
Â
Key deliverables of the report:
â—ŹÂ Â Â Â Â Market CAGR during the forecasting years 2022-2028
â—ŹÂ Â Â Â Â Detailed data highlighting key insights, industry components, and market strategies
â—ŹÂ Â Â Comprehensive information and estimation of the medical enzymes market revenue growth in the Middle East and Africa and its influence on the parent market
â—ŹÂ Â Â Â Â In-depth study of forthcoming trends in consumer behavioral patterns
●     A meticulous analysis of the competitive landscape, vendor scorecard, and Porter’s Five Forces
â—ŹÂ Â A wide-ranging study of factors that will challenge the Middle
East and Africa medical enzymes market’s growth during the upcoming years
Want to get specific insights? Our team of
analysts can customize this report based on your preferences. Connect with us here.Â
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. MIDDLE
EAST AND AFRICA MEDICAL ENZYMES MARKET - SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE MEDICAL ENZYMES MARKET
2.2. KEY
INSIGHTS
2.2.1. ADVANCEMENTS
IN ENZYME ENGINEERING
2.2.2. INCREASED
DEMAND IN THE PHARMACEUTICAL SECTOR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTES
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. KEY
IMPACT ANALYSIS
2.4.1. PRICE
2.4.2. QUALITY
2.4.3. USAGE
2.5. MARKET
ATTRACTIVENESS INDEX
2.6. VENDOR
SCORECARD
2.7. INDUSTRY
COMPONENTS
2.7.1. RESEARCH
AND DEVELOPMENT
2.7.2. OPERATIONS
2.7.3. OUTBOUND
LOGISTICS
2.8. KEY
MARKET STRATEGIES
2.8.1. MERGERS
& ACQUISITIONS
2.8.2. PRODUCT
LAUNCHES & DEVELOPMENTS
2.8.3. PARTNERSHIPS
& AGREEMENTS
2.8.4. BUSINESS
EXPANSIONS & DIVESTITURES
2.9. MARKET
DRIVERS
2.9.1. RISING
INVESTMENTS IN RESEARCH AND DEVELOPMENT
2.9.2. RISING
AGING POPULATION AND OCCURRENCE OF CHRONIC DISEASES
2.9.3. INCREASING
APPLICATIONS IN THE PHARMACEUTICAL INDUSTRY
2.10. MARKET
CHALLENGES
2.10.1. STRICT
REGULATIONS
2.10.2. SAFETY
CONCERNS WHILE HANDLING ENZYMES
2.11. MARKET
OPPORTUNITIES
2.11.1. RISING
HEALTH ISSUES AND GROWING AWARENESS
2.11.2. RISING
DEMAND FOR SPECIALTY ENZYMES
3. MIDDLE
EAST AND AFRICA MEDICAL ENZYMES MARKET OUTLOOK - BY PRODUCT TYPE
3.1. HYDROLASE
3.1.1. HYALURONIDASE
3.1.2. LYSOZYMES
3.1.3. OTHER
HYDROLASES ENZYMES
3.2. THROMBOLYTIC
ENZYME
3.2.1. STREPTOKINASE
3.2.2. UROKINASE
3.2.3. OTHER
THROMBOLYTIC ENZYMES
3.3. DIGESTIVE
ENZYME
3.3.1. LACTASE
3.3.2. L-ASPARAGINASE
3.3.3. OTHER
DIGESTIVE ENZYMES
3.4. ENDONUCLEASE
3.4.1. BENZONASE
3.4.2. OTHER
ENDONUCLEASES
4. MIDDLE
EAST AND AFRICA MEDICAL ENZYMES MARKET OUTLOOK - BY APPLICATION
4.1. DISEASE
TREATMENT
4.2. DIAGNOSTIC
TOOLS
4.3. BIOMEDICAL
RESEARCH
4.4. OTHER
APPLICATIONS
5. MIDDLE
EAST AND AFRICA MEDICAL ENZYMES MARKET – COUNTRY OUTLOOK
5.1. UNITED
ARAB EMIRATES
5.2. SAUDI
ARABIA
5.3. TURKEY
5.4. SOUTH
AFRICA
5.5. REST
OF MIDDLE EAST & AFRICA
6. COMPETITIVE
LANDSCAPE
6.1. BASF
SE
6.2. DUPONT
6.3. ROCHE
HOLDING AG
6.4. NOVOZYMES
6.5. DSM
6.6. SANOFI
SA
6.7. CODEXIS
6.8. ADVANCED
ENZYMES
6.9. AMANO
ENZYME
6.10. BBI
SOLUTIONS
6.11. THERMOFISHER
SCIENTIFIC INC
6.12. CPC
BIOTECH
6.13. NOVUS
6.14. BRAIN
BIOTECH AG
6.15. SEKISUI
7. RESEARCH
METHODOLOGY & SCOPE
7.1. RESEARCH
SCOPE & DELIVERABLES
7.2. SOURCES
OF DATA
7.3. RESEARCH
METHODOLOGY
TABLE 1: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
TABLE 2: APPLICATIONS
OF ENZYMES IN THE PHARMACEUTICALS INDUSTRY
TABLE 3: VENDOR SCORECARD
TABLE 4: LIST OF
MERGERS & ACQUISITIONS
TABLE 5: LIST OF
PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 6: LIST OF
PARTNERSHIPS & AGREEMENTS
TABLE 7: LIST OF
BUSINESS EXPANSIONS & DIVESTITURES
TABLE 8: MEDICAL
APPLICATION OF VARIOUS ENZYMES
TABLE 9: MIDDLE EAST AND
AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2022-2028 (IN $ MILLION)
TABLE 10: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2022-2028 (IN $
MILLION)
TABLE 11: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $
MILLION)
TABLE 12: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $
MILLION)
TABLE 13: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
TABLE 14: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2022-2028 (IN $ MILLION)
TABLE 15: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY COUNTRY, 2022-2028 (IN $ MILLION)
FIGURE 1: KEY BUYING
IMPACT ANALYSIS
FIGURE 2: MARKET ATTRACTIVENESS
INDEX
FIGURE 3: INDUSTRY
COMPONENTS
FIGURE 4: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY PRODUCT TYPE, 2021 & 2028 (IN %)
FIGURE 5: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE, 2022-2028 (IN $ MILLION)
FIGURE 6: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY HYDROLASE ENZYME, 2021 & 2028 (IN %)
FIGURE 7: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY HYALURONIDASE, 2022-2028 (IN $ MILLION)
FIGURE 8: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY LYSOZYMES, 2022-2028 (IN $ MILLION)
FIGURE 9: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER HYDROLASES ENZYMES, 2022-2028 (IN $
MILLION)
FIGURE 10: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2022-2028 (IN $
MILLION)
FIGURE 11: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY THROMBOLYTIC ENZYME, 2021 & 2028 (IN
%)
FIGURE 12: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY STREPTOKINASE, 2022-2028 (IN $ MILLION)
FIGURE 13: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY UROKINASE, 2022-2028 (IN $ MILLION)
FIGURE 14: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER THROMBOLYTIC ENZYMES, 2022-2028 (IN
$ MILLION)
FIGURE 15: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2022-2028 (IN $
MILLION)
FIGURE 16: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY DIGESTIVE ENZYME, 2021 & 2028 (IN %)
FIGURE 17: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY LACTASE, 2022-2028 (IN $ MILLION)
FIGURE 18: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY L-ASPARAGINASE, 2022-2028 (IN $ MILLION)
FIGURE 19: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER DIGESTIVE ENZYMES, 2022-2028 (IN $
MILLION)
FIGURE 20: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY ENDONUCLEASE, 2022-2028 (IN $ MILLION)
FIGURE 21: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY ENDNUCLEASE ENZYME, 2021 & 2028 (IN
%)
FIGURE 22: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY BENZONASE, 2022-2028 (IN $ MILLION)
FIGURE 23: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER ENDONUCLEASES, 2022-2028 (IN $
MILLION)
FIGURE 24: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY APPLICATION, 2021 & 2028 (IN %)
FIGURE 25: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY DISEASE TREATMENT, 2022-2028 (IN $
MILLION)
FIGURE 26: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY DIAGNOSTIC TOOLS, 2022-2028 (IN $
MILLION)
FIGURE 27: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY BIOMEDICAL RESEARCH, 2022-2028 (IN $
MILLION)
FIGURE 28: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, BY OTHER APPLICATIONS, 2022-2028 (IN $
MILLION)
FIGURE 29: MIDDLE EAST
AND AFRICA MEDICAL ENZYMES MARKET, COUNTRY OUTLOOK, 2021 & 2028 (IN %)
FIGURE 30: UNITED ARAB EMIRATES
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 31: SAUDI ARABIA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 32: TURKEY
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 33: SOUTH AFRICA
MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)
FIGURE 34: REST OF
MIDDLE EAST & AFRICA MEDICAL ENZYMES MARKET 2022-2028 (IN $ MILLION)